FRNM is Freenome, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $16.88. Market cap: $1.82B.
Stock snapshot
| Price | $16.88 |
| Market cap | $1.82B |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About FRNM
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
Related non-dividend companies
Other non-dividend stocks investors research alongside FRNM. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is FRNM's current stock price?
FRNM (Freenome, Inc.) is currently trading at $16.88.
Does FRNM pay a dividend?
FRNM (Freenome, Inc.) does not currently pay a regular dividend.
Track FRNM in DiviDrip
Add FRNM to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search FRNM and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.